We only use cookies that are necessary for this site to function to provide you with the best experience. The controller of this site may choose to place supplementary cookies to support additional functionality such as support analytics, and has an obligation to disclose these cookies. Learn more in our Cookie Statement.
HRA Latest, February 2022: Let's talk about ethics review; smoothing the way to confidentiality support and more...
Health Research Authority sent this bulletin at 24-02-2022 01:50 PM GMT
Welcome to HRA Latest, with all the latest updates for those working or involved in health and social care research.
We’ve been finding out what you think is important in ethics review and who you trust to provide that review as part of our Think Ethics work. This month three members of our Public Involvement Network, Louise, Lynn and Della, have blogged about their experience as part of our workshops.
Making research approvals more simple is still one of our top priorities. Find out how we’re making applications more straightforward for studies that need both confidentiality and ethics review.
As always, for the latest news you can follow us on Twitter @HRA_Latest.
Karen Williams, Deputy Chief Executive
Let's talk about ethics review
We’ve been finding out what you think is important in ethics review and who you trust to provide that review. It’s part of our Think Ethics work, and this month three members of our Public Involvement Network, Louise, Lynn and Della, have blogged about their experience as part of our workshops.
As part of wider work to streamline our processes, we’re looking at how we can better align applications for studies that need both Confidentiality Advisory Group (CAG) advice and a Research Ethics Committee (REC) opinion.
A blog by Paul Mills, Confidentiality Advice Service Manager, explains the difference this could make.
Now is your chance to improve public involvement in UK clinical trials
We’re working with the Medicines and Healthcare products Regulatory Agency (MHRA) on proposals to improve and strengthen UK clinical trials legislation. Our Public Involvement Lead, Jim Elliott, blogs about how you can help inform change.
Reducing the time to set up commercial studies in the UK
We’re helping to reduce the time, cost and resources needed to set up health and social care research in the UK by launching new templates for studies that are sponsored by a commercial company.